financetom
Business
financetom
/
Business
/
Compass Insider Sold Shares Worth $1,774,258, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Compass Insider Sold Shares Worth $1,774,258, According to a Recent SEC Filing
Feb 14, 2025 12:51 AM

03:33 AM EST, 02/14/2025 (MT Newswires) -- Robert L. Reffkin, Director, Chairman and Chief Executive Officer, on February 11, 2025, sold 224,510 shares in Compass (COMP) for $1,774,258. Following the Form 4 filing with the SEC, Reffkin has control over a total of 8,967,252 Class A common shares of the company, with 1,139,136 shares held directly and 7,828,116 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1563190/000156319025000029/xslF345X05/wk-form4_1739498258.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Agree Realty Keeps Monthly Dividend at $0.247 a Share, Payable April 12 to Holders of Record March 28
--Agree Realty Keeps Monthly Dividend at $0.247 a Share, Payable April 12 to Holders of Record March 28
Mar 12, 2024
04:51 PM EDT, 03/12/2024 (MT Newswires) -- Price: 57.82, Change: +0.6, Percent Change: +1.05 ...
Incyte's Povorcitinib Potentially Suited for Hidradenitis Suppurativa, Prurigo Nodularis, RBC Says
Incyte's Povorcitinib Potentially Suited for Hidradenitis Suppurativa, Prurigo Nodularis, RBC Says
Mar 12, 2024
04:53 PM EDT, 03/12/2024 (MT Newswires) -- Incyte's ( INCY ) povorcitinib has the potential to treat patients with hidradenitis suppurativa and prurigo nodularis, while opzelura is less likely to be used for mild hidradenitis suppurativa, RBC Capital Markets said in an emailed Tuesday. Hidradenitis suppurativa and prurigo nodularis are both skin conditions. The latest phase 2 data of povorcitinib...
Mass torts against 3M, J&J fueled spike in new federal lawsuits in 2023
Mass torts against 3M, J&J fueled spike in new federal lawsuits in 2023
Mar 12, 2024
* Judiciary says overall filings in federal court rose 18% in 2023 * Criminal cases fell 3% By Nate Raymond March 12 (Reuters) - The number of new federal lawsuits jumped 24% in the 2023 fiscal year as cases by people alleging they were injured by products like 3M's ( MMM ) combat earplugs and Johnson & Johnson's ( JNJ...
BRIEF-Suke Files For U.S. IPO Of Up To 2.0 Million Ordinary Shares - SEC Filing
BRIEF-Suke Files For U.S. IPO Of Up To 2.0 Million Ordinary Shares - SEC Filing
Mar 12, 2024
March 12 (Reuters) - * SUKE LTD FILES FOR U.S. IPO OF UP TO 2.0 MILLION ORDINARY SHARES - SEC FILING * SUKE LTD SAYS ANTICIPATES IPO PRICE PER ORDINARY SHARE WILL BE BETWEEN $4.00 AND $6.00 * SUKE LTD SAYS IN ADDITION, 1.75 MILLION ORDINARY SHARES WILL BE OFFERED FOR POTENTIAL RESALE BY SELLING SHAREHOLDERS * SUKE LTD SAYS...
Copyright 2023-2025 - www.financetom.com All Rights Reserved